Skip to main content
TECNOVAX S.A. logo

TECNOVAX S.A. — Investor Relations & Filings

ISIN · ARTNVX560020 BYMA Manufacturing
Open in API
Filings indexed 121 across all filing types
Latest filing 2026-05-11 Interim / Quarterly Rep…
Country AR Argentina
Listing BYMA

About TECNOVAX S.A.

https://tecnovax.com/en/home-eng/

TECNOVAX S.A. is a biotechnology company dedicated to animal health, specializing in the research, development, and production of vaccines and immunotherapies. Leveraging its scientific expertise and decades of research, the company delivers safe and effective biological products for disease prevention. Its product portfolio targets a wide range of animals, including livestock such as ruminants and equines, aquatic species like salmonids, and companion animals including dogs and cats.

Recent filings

Filing Released Lang Actions
NORMA CONTABLE: NCP - TIPO BALANCE: INDIVIDUAL - PERIODICIDAD: TRIMESTRAL - FECHA CIERRE: 2026-03-31 - ESTADOS CONTABLES - PYMES CNV, ADC, ACRYP Y CC
Interim / Quarterly Report Classification · 90% confidence The document is a full set of interim financial statements (balance sheet, income statement, cash flow, statement of changes in equity), including an independent auditor’s review report, for the three-month period ended March 31, 2026. It is not an announcement or summary earnings release but the substantive quarterly report itself. This matches the definition of an Interim/Quarterly Report (IR). Q1 2026
2026-05-11 Spanish
FEC. CELEB.: 08-05-2026 - TEMA: 5 - ACTA DE ÓRGANO DE ADMINISTRACIÓN (DIRECTORIO)
Regulatory Filings Classification · 75% confidence The document is the minutes (acta) of a Board of Directors meeting where the quarterly financial statements for the three months ended March 31, 2026, are approved. It does not itself contain the financial data or present an interim report but rather the resolution to approve and sign the statements. It is not a change in management, press release of results, or detailed investor presentation; it is a corporate governance record (board minutes) and thus falls under the generic regulatory filing category.
2026-05-08 Spanish
FEC. CELEB.: 30-03-2026 - APRUEBA EECC: SI - ACTA DE ASAMBLEA Y/O REUNIÓN DE SOCIOS03
Regulatory Filings
2026-04-22 Spanish
FECHA CIERRE: 2026-03-31 - INFORME TRIMESTRAL DE ON
Interim / Quarterly Report Classification · 95% confidence The document is titled as a "Quarterly Report on the Issuance of Negotiable Obligations, CEDEAR, Other Debt Securities and/or Participation Certificates" with a specific quarterly period ending March 31, 2026. It contains detailed financial and issuance data about debt securities, including authorization dates, amounts, interest rates, maturity dates, and other issuance conditions. The length of the document (6982 characters) and the detailed financial data indicate it is a substantive financial report rather than a brief announcement or certification. The content aligns with a quarterly or interim financial report rather than an annual report or other filing types. Therefore, the document fits the definition of an Interim / Quarterly Report (IR). Q1 2026
2026-04-08 Spanish
FEC. CELEB.: 30-03-2026 - TEMA: 6 - ACTA DE ÓRGANO DE ADMINISTRACIÓN (DIRECTORIO)
Regulatory Filings
2026-04-01 Spanish
FEC. CELEB.: 30-03-2026 - TEMA: 6 - ACTA DE ÓRGANO DE ADMINISTRACIÓN (DIRECTORIO)
Regulatory Filings
2026-04-01 Spanish

Browse filings by year

4 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.